O
NXTM

OrbiMed’s NxStage Medical Inc. NXTM Stock Holding History

OrbiMed’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-795,200
Closed -$11.4M – 148
2014
Q2 		$11.4M Sell
795,200
-1,317,800
-62% -$17.2M 0.13% 78
2014
Q1 		$26.9M Sell
2,113,000
-566,216
-21% -$7.39M 0.33% 53
2013
Q4 		$26.8M Sell
2,679,216
-435,284
-14% -$4.94M 0.39% 54
2013
Q3 		$41M Sell
3,114,500
-106,600
-3% -$1.4M 0.73% 38
2013
Q2 		$46M Buy
+3,221,100
New +$40.5M 0.98% 33

Other funds holding NXTM

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
BA
Broadview Advisors Milwaukee, Wisconsin $324M AUM 0.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

OrbiMed's NXTM Position: Q3 2014 in Review

OrbiMed sold out of NxStage Medical Inc. (NXTM) in Q3 2014, closing a stake of 795,200 shares — an estimated $11.4M sold.

OrbiMed first reported a position in NXTM in Q2 2013 and held it in 5 quarters. The position peaked at $46M in Q2 2013. 111 funds tracked by Wall St. Rank hold NXTM as of Q3 2014.

  • OrbiMed reported no remaining NxStage Medical Inc. position as of Q3 2014 after selling out during the quarter.
  • OrbiMed sold 795,200 NxStage Medical Inc. shares in Q3 2014, an estimated $11.4M.
  • OrbiMed first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 5 quarters.
  • OrbiMed's NxStage Medical Inc. position peaked at $46M in Q2 2013.
  • 111 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q3 2014.

Based on OrbiMed's 13F filing for Q3 2014, filed 14 Nov 2014.